Defibrotide

Rare liver disorder drug from Jazz wins U.S. approval
Yahoo/Reuters
Wed, 03/30/16 - 09:19 pm
Jazz Pharmaceuticals
FDA
hepatic veno-occlusive disease
liver disease
Defibrotide
4 Pharmaceutical Stocks With Big Catalysts Pending in 2016
24/7 Wall St
Fri, 01/8/16 - 09:43 am
Jazz Pharmaceuticals
Defibrotide
Clovis Oncology
rociletinib
Insys
Dronabinol
Gilead Sciences
F/TAF
Jazz eyes a quick FDA nod for its $1B rare disease drug
Fierce Biotech
Wed, 09/30/15 - 04:49 pm
Jazz Pharmaceuticals
FDA
Defibrotide
hepatic veno-occlusive disease
Jazz heads to the FDA with its $1B rare disease drug
Fierce Biotech
Mon, 12/15/14 - 08:28 am
Jazz Pharmaceuticals
FDA
Defibrotide
Gentium
Jazz Pharma Buys Out Rights To Newly Acquired Drug
Investors.com
Wed, 07/2/14 - 04:38 pm
Jazz Pharmaceuticals
Defibrotide
Sigma-Tau
Gentium
hepatic veno-occlusive disease
Gentium announces completion of defibrotide Phase 1 study in Japan
The Fly on the Wall
Tue, 11/12/13 - 09:48 am
Defibrotide
Japan
Gentium
Gentium: Several Underappreciated Investment Positives
Seeking Alpha
Mon, 09/9/13 - 09:51 am
Gentium
Defibrotide
Gentium tumbles 29% on drug setback, downgrade
Marketwatch
Thu, 08/18/11 - 05:44 pm
Gentium
Defibrotide
Gentium Announces NDA Submission for Defibrotide
Yahoo
Wed, 07/6/11 - 08:15 am
Gentium
NDA
Defibrotide
FDA
veno-occlusive disease